Severe community-acquired pneumonia (sCAP) is a major global health challenge, with high morbidity and mortality, especially ...

Objectives Infliximab, an anti-TNF agent, is used to treat sarcoidosis that does not respond to corticosteroids or second-line agents. The efficacy of other anti-TNF agents, non-TNF biologics and ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

Introduction Tocilizumab improves outcomes in critically ill patients with COVID-19. Whether other immune-modulator strategies are equally effective or better is unknown. Methods We investigated ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

Oxford Children's Hospital, The John Radcliffe, Headington, Oxford, UK Correspondence to Dr Anne Thomson, Oxford Children's Hospital, The John Radcliffe, Headley Way, Headington, Oxford OX3 9DU, UK; ...

1 Consultant in Paediatric Accident and Emergency and General Paediatrics, Chelsea and Westminster Hospital, London, UK 2 Consultant in Paediatric Respiratory Medicine, Royal Brompton Hospital, London ...

Department of Complementary Medicine, School of Sport and Health Studies, University of Exeter, Exeter EX2 4NT, UK Correspondence to: Dr A Huntley, Department of Complementary Medicine, School of ...

11 NIHR Health Protection Research Unit, Institute of Infection, Veterinary and Ecological Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK Purpose To ...

Department of Gerontology and Geriatrics, Leiden University Medical Centre, Leiden, The Netherlands Dr J Gussekloo, Department of Public Health and Primary Care, Leiden University Medical Center, Post ...

Background Poorly controlled asthma is associated with increased morbidity and healthcare resource utilisation (HCRU). Therefore, to quantify the environmental impact of asthma care, this ...

BACKGROUND Patients with cystic fibrosis (CF) have many risk factors for reduced bone mineral density (BMD). The aim of this study was to determine the prevalence of osteoporosis and osteopenia in a ...